Thymol Inhibits Biofilm Formation, Eliminates Pre-Existing Biofilms, and Enhances Clearance of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Mouse Peritoneal Implant Infection Model
Thymol Inhibits Biofilm Formation, Eliminates Pre-Existing Biofilms, and Enhances Clearance of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Mouse Peritoneal Implant Infection Model
复制标题
在小鼠腹膜植入物感染模型中,百里酚抑制生物膜形成、消除预先存在的生物膜并增强耐甲氧西林金黄色葡萄球菌 (MRSA) 的清除
DOI:
10.3390/microorganisms8010099
复制
发表时间:
2020-01
期刊:
影响因子:
4.5
通讯作者:
Yin Lizi
中科院分区:
文献类型:
--
作者:
Yuan Zhongwei;Dai Yuyun;Ouyang Ping;Rehman Tayyab;Hussain Sajjad;Zhang Tianyi;Yin Zhongqiong;Fu Hualin;Lin Juchun;He Changliang;Lv Cheng;Liang Xiaoxia;Shu Gang;Song Xu;Li Lixia;Zou Yuanfeng;Yin Lizi
Methicillin-resistant Staphylococcus aureus (MRSA) is a common human pathogen that causes several difficult-to-treat infections, including biofilm-associated infections. The biofilm-forming ability of S. aureus plays a pivotal role in its resistance to most currently available antibiotics, including vancomycin, which is the first-choice drug for treating MRSA infections. In this study, the ability of thymol (a monoterpenoid phenol isolated from plants) to inhibit biofilm formation and to eliminate mature biofilms, was assessed. We found that thymol could inhibit biofilm formation and remove mature biofilms by inhibiting the production of polysaccharide intracellular adhesin (PIA) and the release of extracellular DNA (eDNA). However, cotreatment with thymol and vancomycin was more effective at eliminating MRSA biofilms, in a mouse infection model, than monotherapy with vancomycin. Comparative histopathological analyses revealed that thymol reduced the pathological changes and inflammatory responses in the wounds. Assessments of white blood cell counts and serum TNF-α and IL-6 levels showed reduced inflammation and an increased immune response following treatment with thymol and vancomycin. These results indicate that combinatorial treatment with thymol and vancomycin has the potential to serve as a more effective therapy for MRSA biofilm-associated infections than vancomycin monotherapy.
登录
查看更多内容
DOI:
10.1016/s0093-3619(08)70765-2
发表时间:
2008
期刊:
Yearbook of Dermatology and Dermatologic Surgery
影响因子:
--
作者:
B. Thiers
通讯作者:
B. Thiers
DOI:
10.3390/pathogens3020404
发表时间:
2014-05-06
期刊:
Pathogens (Basel, Switzerland)
影响因子:
--
作者:
Amalaradjou MA;Venkitanarayanan K
通讯作者:
Venkitanarayanan K
影响因子:
4.2
作者:
Ouyang P;He X;Yuan ZW;Yin ZQ;Fu H;Lin J;He C;Liang X;Lv C;Shu G;Yuan ZX;Song X;Li L;Yin L
通讯作者:
Yin L
DOI:
10.1056/nejm199812313392716
发表时间:
1998-12
期刊:
The New England journal of medicine
影响因子:
--
作者:
S. Blot;K. Vandewoude;F. Colardyn
通讯作者:
S. Blot;K. Vandewoude;F. Colardyn
影响因子:
3.7
作者:
Luo, Jing;Dong, Biying;Chen, Yiqiang
通讯作者:
Chen, Yiqiang